Modified Duke/European Society of Cardiology 2015 clinical criteria for infective endocarditis: time for an update?
Delivery of Health Care
Echocardiography
Endocarditis
Journal
Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
received:
14
09
2021
accepted:
21
04
2022
entrez:
9
5
2022
pubmed:
10
5
2022
medline:
12
5
2022
Statut:
ppublish
Résumé
The diagnosis of infective endocarditis (IE) is based on the modified Duke/European Society of Cardiology (ESC) 2015 clinical criteria. The sensitivity of the criteria is unknown in South Africa, but high rates of blood culture negative endocarditis (BCNIE), coupled with a change in the clinical features of IE, may limit the sensitivity. The Tygerberg Endocarditis Cohort study prospectively enrolled patients with IE between November 2019 and June 2021. A standardised protocol for organism detection, with management of patients by an Endocarditis Team, was employed. Patients with definite IE by pathological criteria were analysed to determine the sensitivity of the current clinical criteria. Eighty consecutive patients with IE were included of which 45 (56.3%) had definite IE by pathological criteria. In patients with definite IE by pathological criteria, 26/45 (57.8%) of patients were classified as definite IE by clinical criteria. BCNIE was present in 25/45 (55.6%) of patients and less than three minor clinical criteria were present in 32/45 (75.6%) of patients. The elevation of The sensitivity of the modified Duke/ESC 2015 clinical criteria is lower than expected in patients with IE in South Africa, primarily due to the high rates of
Sections du résumé
BACKGROUND
The diagnosis of infective endocarditis (IE) is based on the modified Duke/European Society of Cardiology (ESC) 2015 clinical criteria. The sensitivity of the criteria is unknown in South Africa, but high rates of blood culture negative endocarditis (BCNIE), coupled with a change in the clinical features of IE, may limit the sensitivity.
METHODS
The Tygerberg Endocarditis Cohort study prospectively enrolled patients with IE between November 2019 and June 2021. A standardised protocol for organism detection, with management of patients by an Endocarditis Team, was employed. Patients with definite IE by pathological criteria were analysed to determine the sensitivity of the current clinical criteria.
RESULTS
Eighty consecutive patients with IE were included of which 45 (56.3%) had definite IE by pathological criteria. In patients with definite IE by pathological criteria, 26/45 (57.8%) of patients were classified as definite IE by clinical criteria. BCNIE was present in 25/45 (55.6%) of patients and less than three minor clinical criteria were present in 32/45 (75.6%) of patients. The elevation of
CONCLUSION
The sensitivity of the modified Duke/ESC 2015 clinical criteria is lower than expected in patients with IE in South Africa, primarily due to the high rates of
Identifiants
pubmed: 35534094
pii: openhrt-2021-001856
doi: 10.1136/openhrt-2021-001856
pmc: PMC9086646
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Echo Res Pract. 2018 Mar 23;:
pubmed: 29572293
Clin Infect Dis. 1996 Aug;23(2):298-302
pubmed: 8842267
QJM. 2003 Mar;96(3):217-25
pubmed: 12615986
S Afr Med J. 2019 Jul 26;109(8):592-596
pubmed: 31456555
J Am Coll Cardiol. 1999 Jun;33(7):2023-9
pubmed: 10362209
Open Heart. 2020 Nov;7(2):
pubmed: 33154146
Lancet Glob Health. 2022 Jan;10(1):e8-e9
pubmed: 34919860
BMJ Open. 2021 Dec 6;11(12):e053169
pubmed: 34873007
Echo Res Pract. 2017 Dec;4(4):R43-R52
pubmed: 28864463
Am J Med. 1994 Mar;96(3):200-9
pubmed: 8154507
Eur J Cardiothorac Surg. 2017 Oct 1;52(4):616-664
pubmed: 29156023
Lancet. 2016 Feb 27;387(10021):882-93
pubmed: 26341945
Patholog Res Int. 2016;2016:8132741
pubmed: 27088035
Echo Res Pract. 2015 Mar 1;2(1):G9-G24
pubmed: 26693316
Infection. 2017 Apr;45(2):199-207
pubmed: 27771866
Echocardiography. 2020 Jun;37(6):808-814
pubmed: 32524654
Cardiovasc Diagn Ther. 2020 Apr;10(2):252-261
pubmed: 32420108
Eur Heart J. 2019 Oct 14;40(39):3222-3232
pubmed: 31504413
Int J Infect Dis. 2021 Mar;104:556-561
pubmed: 33508475
Echocardiography. 2021 May;38(5):729-736
pubmed: 33847025
Echo Res Pract. 2015 Dec 1;2(4):G29-45
pubmed: 26798487
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Pediatrics. 2003 Dec;112(6 Pt 1):e467
pubmed: 14654647
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1873-1879
pubmed: 33829350
S Afr Med J. 2022 Apr 30;112(5):321-327
pubmed: 35587244
Emerg Infect Dis. 2017 Aug;23(8):
pubmed: 28730981